AI Article Synopsis

  • The rise of bacterial resistance to antibiotics is a significant public health issue, largely due to misuse and over-prescription of these medications, particularly for common infections like upper respiratory issues.
  • Otorhinolaryngologists are crucial in guiding both patients and other healthcare providers on the correct and rational use of antibiotics for conditions such as otitis media and rhinosinusitis.
  • Ongoing updates to guidelines and continuous education are essential to change the mindset that antibiotics are always necessary for upper respiratory infections, aiming to reduce inappropriate usage and its associated risks.

Article Abstract

Introduction: Bacterial resistance burden has increased in the past years, mainly due to inappropriate antibiotic use. Recently it has become an urgent public health concern due to its impact on the prolongation of hospitalization, an increase of total cost of treatment and mortality associated with infectious disease. Almost half of the antimicrobial prescriptions in outpatient care visits are prescribed for acute upper respiratory infections, especially rhinosinusitis, otitis media, and pharyngotonsillitis. In this context, otorhinolaryngologists play an important role in orienting patients and non-specialists in the utilization of antibiotics rationally and properly in these infections.

Objectives: To review the most recent recommendations and guidelines for the use of antibiotics in acute otitis media, acute rhinosinusitis, and pharyngotonsillitis, adapted to our national reality.

Methods: A literature review on PubMed database including the medical management in acute otitis media, acute rhinosinusitis, and pharyngotonsillitis, followed by a discussion with a panel of specialists.

Results: Antibiotics must be judiciously prescribed in uncomplicated acute upper respiratory tract infections. The severity of clinical presentation and the potential risks for evolution to suppurative and non-suppurative complications must be taken into 'consideration'.

Conclusions: Periodic revisions on guidelines and recommendations for treatment of the main acute infections are necessary to orient rationale and appropriate use of antibiotics. Continuous medical education and changes in physicians' and patients' behavior are required to modify the paradigm that all upper respiratory infection needs antibiotic therapy, minimizing the consequences of its inadequate and inappropriate use.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449220PMC
http://dx.doi.org/10.1016/j.bjorl.2018.02.001DOI Listing

Publication Analysis

Top Keywords

upper respiratory
16
otitis media
12
respiratory tract
8
acute upper
8
acute otitis
8
media acute
8
acute rhinosinusitis
8
rhinosinusitis pharyngotonsillitis
8
acute
7
antibiotics
5

Similar Publications

Unlabelled: Intracranial complications in inflammatory diseases of the ear and nose are currently not frequent, but their lethality remains high. The choice of optimal, safe and effective access in surgical treatment of purulent-inflammatory intracranial complications remains a subject of discussions and is based on an individual approach, depends on the volume, localization and clinical condition of the patient.

Objective: To demonstrate a clinical case of successful drainage of the brain frontal lobe abscess using endoscopic transnasal access under the control of the navigation system.

View Article and Find Full Text PDF

Mortality Profile of Deaths Related to Infective Endocarditis in Brazil and Regions: A Population-Based Analysis of Death Records.

Trop Med Infect Dis

November 2024

Department of Specialized Medicine-Cardiology Discipline, School of Medicine and Surgery, Federal University of the State of Rio de Janeiro, Rua Silva Ramos, 32, Tijuca, Rio de Janeiro 20270-330, Brazil.

Background: Studies of infective endocarditis (IE) are generally limited to institutions, underlining the need for more comprehensive epidemiological research.

Objective: The aim of this study was to determine the mortality profile of IE-related deaths and related causes in Brazil at the national level and across regions.

Method: We conducted a population-based study using data from the country's mortality information system for the period 2000 to 2019.

View Article and Find Full Text PDF

Vitamin D supplements reduce risk of viral upper respiratory infections in children with lower concentrations.

Acta Paediatr

December 2024

Department of Medicine, Paediatric Outpatient Clinic, Helgeland Hospital, Sandnessjøen, Norway.

Aim: Vitamin D is crucial for the immune system, as it enhances pathogen-fighting cells and reduces inflammation. We reviewed serum 25-hydroxyvitamin D (25(OH)D) concentrations in children with viral upper respiratory tract infections (URTIs) and the impact of vitamin D supplements on those infections.

Methods: A mini literature review was conducted from 1 January 2000 to 30 April 2024.

View Article and Find Full Text PDF

Background: Approximately 30% of coronavirus disease 2019 COVID-19 patients develop fatigue and psychological symptoms. We previously demonstrated the efficacy of donepezil, an acetylcholinesterase inhibitor that is widely used to treat dementia, in basic research.

Methods: This is a multicenter, double-blind, randomized, controlled, phase II clinical trial in which 120 patients with COVID-19 will be randomized in a 1:1 ratio to a donepezil or placebo group.

View Article and Find Full Text PDF

European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned.

Front Allergy

December 2024

Department of Otorhinolarynogology and Head/Neck Surgery, Amsterdam University Medical Centres, Location AMC, University of Amsterdam, Amsterdam, Netherlands.

The European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized the first European Biologic Training Course (EBTC) in Brussels on 1st March 2024. The aim of this hybrid EBTC including both face-to-face and web-based participation was to address the educational needs of physicians dealing with asthma and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) on the clinically relevant aspects of diagnosing and treatment with biologics. EUFOREA is an international non-for-profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic respiratory diseases through the implementation of optimal patient care via educational, research, and advocacy activities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!